Loss of Function of E-Cadherin in Embryonic Stem Cells and the Relevance to Models of TumorigenesisReport as inadecuate

Loss of Function of E-Cadherin in Embryonic Stem Cells and the Relevance to Models of Tumorigenesis - Download this document for free, or read online. Document in PDF available to download.

Journal of OncologyVolume 2011 2011, Article ID 352616, 19 pages

Review ArticleCore Technology Facility, Faculty of Medical and Human Sciences, The University of Manchester, 46 Grafton Street, Manchester M13 9NT, UK

Received 1 August 2010; Revised 15 October 2010; Accepted 26 October 2010

Academic Editor: Eric Deutsch

Copyright © 2011 Lisa Mohamet et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


E-cadherin is the primary cell adhesion molecule within the epithelium, and loss of this protein is associated with a more aggressive tumour phenotype and poorer patient prognosis in many cancers. Loss of E-cadherin is a defining characteristic of epithelial-mesenchymal transition EMT, a process associated with tumour cell metastasis. We have previously demonstrated an EMT event during embryonic stem ES cell differentiation, and that loss of E-cadherin in these cells results in altered growth factor response and changes in cell surface localisation of promigratory molecules. We discuss the implication of loss of E-cadherin in ES cells within the context of cancer stem cells and current models of tumorigenesis. We propose that aberrant E-cadherin expression is a critical contributing factor to neoplasia and the early stages of tumorigenesis in the absence of EMT by altering growth factor response of the cells, resulting in increased proliferation, decreased apoptosis, and acquisition of a stem cell-like phenotype.

Author: Lisa Mohamet, Kate Hawkins, and Christopher M. Ward

Source: https://www.hindawi.com/


Related documents